Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Shujuan Zhou"'
Autor:
Danyang Li, Yigang Yuan, Chen Meng, Zihan Lin, Min Zhao, Liuzhi Shi, Min Li, Daijiao Ye, Yue Cai, Xiaofei He, Haige Ye, Shujuan Zhou, Haixia Zhou, Shenmeng Gao
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-17 (2024)
Abstract Background miR-182 promoter hypermethylation frequently occurs in various tumors, including acute myeloid leukemia, and leads to low expression of miR-182. However, whether adult acute lymphocyte leukemia (ALL) cells have high miR-182 promot
Externí odkaz:
https://doaj.org/article/c44c05750ee741bc967316cdfdac82e9
Autor:
Shujuan Zhou, Jie Che, Xuran Wang, Yong Lin, Jianjun Niu, Weitong Liang, Li Xu, Maojun Zhang, Yiqun Liao, Zhujun Shao, Qingge Li
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 1, Pp 107-117 (2024)
Background: Pneumococcus serotyping is important for monitoring serotype epidemiology, vaccine-induced serotypes replacement and emerging pathogenic serotypes. However, the lack of high-resolution serotyping tools has hindered its widespread implemen
Externí odkaz:
https://doaj.org/article/5aceb2116ae9456bafdf98529c7da121
Autor:
Zhili Lin, Quanqiang Wang, Ziwei Zheng, Bingxin Zhang, Shujuan Zhou, Dong Zheng, Zixing Chen, Sisi Zheng, Shuxia Zhu, Xinyi Zhang, Enqing Lan, Yu Zhang, Xuanru Lin, Qiang Zhuang, Honglan Qian, Xudong Hu, Yan Zhuang, Zhouxiang Jin, Songfu Jiang, Yongyong Ma
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Significant progress has been achieved in the management of multiple myeloma (MM) by implementing high-dose therapy and stem cell transplantation. Moreover, the prognosis of patients has been enhanced due to the introduction of novel immu
Externí odkaz:
https://doaj.org/article/3db4b5fed0db433985ce4debd343d44f
Autor:
Tianyu Zhang, Zhili Lin, Ziwei Zheng, Quanqiang Wang, Shujuan Zhou, Bingxin Zhang, Dong Zheng, Zixing Chen, Sisi Zheng, Yu Zhang, Xuanru Lin, Rujiao Dong, Jingjing Chen, Honglan Qian, Xudong Hu, Yan Zhuang, Qianying Zhang, Zhouxiang Jin, Songfu Jiang, Yongyong Ma
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeTo assess the prognostic significance of β2-microglobulin decline index (β2M DI) in multiple myeloma (MM).Methods150 MM patients diagnosed with MM were enrolled in this study. Cox proportional hazards model was used to analyze the uni- and m
Externí odkaz:
https://doaj.org/article/e41daaa385924a70b069db25e0b8bc6a
Autor:
Yan Wang, Hui Zhang, Fangqi Liu, Sanjun Cai, Lijun Shen, Zhen Zhang, Yaqi Li, Ruiyan Wu, Fan Xia, Shujuan Zhou, Yaqi Wang, Yajie Chen, Juefeng Wan, Menglong Zhou, Yiqun Sun
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Introduction The preliminary result of the TORCH trial has shown a promising complete response (CR) for managing locally advanced rectal cancer with neoadjuvant short-course radiotherapy (SCRT) combined with chemotherapy and PD-1 inhibitor. For local
Externí odkaz:
https://doaj.org/article/f24e8be615c34821a1927dc86f6079f3
Autor:
Peiyuan Mu, Shujuan Zhou, Tao Lv, Fan Xia, Lijun Shen, Juefeng Wan, Yaqi Wang, Hui Zhang, Sanjun Cai, Junjie Peng, Guoqiang Hua, Zhen Zhang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-16 (2023)
Abstract Immunotherapy as a rapidly developing therapeutic approach has revolutionized cancer treatment and revitalized the field of tumor immunology research. 3D in vitro models are emerging as powerful tools considering their feature to maintain tu
Externí odkaz:
https://doaj.org/article/da59ef95fc0346558ab56ab5b21d6621
Autor:
Juefeng Wan, Ruiyan Wu, Miaomiao Fu, Lijun Shen, Hui Zhang, Yan Wang, Yaqi Wang, Shujuan Zhou, Yajie Chen, Fan Xia, Zhen Zhang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
For patients with locally recurrent rectal cancer (LRRC), the response rate to chemoradiotherapy is 40%–50%. Additionally, only approximately 40%–50% of patients with recurrent rectal cancer are able to undergo R0 resection. Recent studies in loc
Externí odkaz:
https://doaj.org/article/663e8cf27611460bb2722e28978e471f
Autor:
Ruihan Xu, Qin Wang, Junmeng Zhu, Yuncheng Bei, Yanhong Chu, Zhichen Sun, Shiyao Du, Shujuan Zhou, Naiqing Ding, Fanyan Meng, Baorui Liu
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 6, Pp n/a-n/a (2023)
Abstract T cell receptor‐engineered T (TCR‐T) cell therapy has demonstrated therapeutic effects in basic research and clinical trials for treating solid tumors. Due to the peptide‐dependent recognition and the human leukocyte antigen (HLA)‐re
Externí odkaz:
https://doaj.org/article/8f35a83d63144ce2a913fb085e2edbeb
Autor:
Yan Wang, Hui Zhang, Sanjun Cai, Lijun Shen, Wang Yang, Zhen Zhang, Ruiyan Wu, Fan Xia, Shujuan Zhou, Xinxiang Li, Yaqi Wang, Yajie Chen, Juefeng Wan, Menglong Zhou
Publikováno v:
BMJ Open, Vol 13, Iss 10 (2023)
Introduction Current standard treatment for patients with early rectal cancer is radical surgical resection. Although radical surgery provides effective local tumour control, it also increases the mortality risk and considerable adverse effects, incl
Externí odkaz:
https://doaj.org/article/65a4e3e49dde4af797861b88eda8f089
Autor:
Shujuan Zhou, Chenchen Wang, Lijun Shen, Yan Wang, Hui Zhang, Ruiyan Wu, Yaqi Wang, Yajie Chen, Yan Xuan, Fan Xia, Zhen Zhang, Juefeng Wan
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Combination strategies to improve immunotherapy response in microsatellite stable metastatic colorectal cancer (MSS mCRC) remain an unmet need. Several single-arm clinical trials have shown promising synergistic effects between regorafenib and ICIs;
Externí odkaz:
https://doaj.org/article/698ac0eee2754370b446935550a155e9